Source: Annual Congress 2001 - Inhalation technology and respiratory measurement in disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Lehmann, S. E. Vollset, A. Gulsvik (Bergen, Norway). Applicability of adrenergic bronchodilatation test in a general population. Eur Respir J 2001; 16: Suppl. 31, 899

Member's Comments

No comment yet.

Related content which might interest you: Testing bronchodilator responsiveness Source: Eur Respir J, 54 (6) 1902036; 10.1183/13993003.02036-2019 Year: 2019 Testing bronchodilator responsiveness Source: Eur Respir J, 54 (6) 1902104; 10.1183/13993003.02104-2019 Year: 2019 Cough provocation test by capsaicin inhalation and its safety in Chinese people Source: Eur Respir J 2005; 26: Suppl. 49, 301s Year: 2005 Protective effect of inhaled anticholinergic drugs in the methacholine test Source: Eur Respir J 2007; 30: Suppl. 51, 619s Year: 2007 Evaluation of bronchodilator response in healthy subjects using pulmonary function test and impulse oscillometry system Source: International Congress 2016 – Lung function and imaging: new findings and new approaches Year: 2016 Airway calibre variability by forced oscillation technique: a sensitive indicator of bronchodilator effect in asthmatic children Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005 A comparison of spirometry and airways resistance during histamine challenge testing Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009 Use of multifactor-dimensionality reduction model predicting bronchodilator response by inhaled short-acting beta 2 agonist Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 Comparison of long acting β 2-agonist inhalers for treatment of exercise-induced bronchoconstriction (EIB) Source: Eur Respir J 2003; 22: Suppl. 45, 312s Year: 2003 Effects of inhaled histamine and methacholine on the lung function parameters obtained by spirometry and forced oscillations in asthmatic children Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 Comparison of bronchodilator responsiveness between forced oscillation technique and spirometry Source: International Congress 2018 – Improvements in the assessment of paediatric physiology Year: 2018 A comparison between the diagnostic value of bronchodilator response in spirometry and questionnaire in determining asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Diagnostic performance of the weight-corrected methacholine bronchial challenge test in children Source: Eur Respir J 2002; 20: Suppl. 38, 172s Year: 2002 Perception of methacholine induced bronchoconstriction according to anxiety sensitivity in a population of mild-to-moderate asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 104s Year: 2001 The evaluation of pharmacogenetic relationship of beta 2-adrenoceptors and response to salmeterol Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Use of impulse oscillometry in the bronchial provocation testing with histamine in the male army recruits Source: Annual Congress 2009 - Respiratory physiology Year: 2009 Airway resistance assessed by impulse oscillometry at varying respiratory rate and the effect of pretreatment with short-acting β2 agonist in COPD patients Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Will a cumulative dose reversibility test increase the power in a dose-response study comparing formoterol and terbutaline? Source: Eur Respir J 2001; 18: Suppl. 33, 514s Year: 2001 A novel dual-agonist challenge model in guinea pigs for assessment of individual and combined muscarinics antagonists and b2 adrenoceptor agonists bronchodilator efficacy Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Use of partition tree to Identify genetic marker combination predicting bronchodilator response by inhaled short-acting beta 2 agonist Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011